Elekta to deliver latest brain radiosurgery system to University
of Virginia
Stockholm, Sweden. The University of Virginia Health System (U.Va.) will
become one of the first centres in the world to install Elekta's (STO:EKTAB)
new Leksell Gamma Knife Perfexion, the company's most advanced system for
non-invasive radiosurgery for brain disorders. It is scheduled for
installation in early spring 2007,
"We are very pleased with the assignment to equip one of the
pioneering institutions in Gamma Knife surgery with this groundbreaking
new system," said Tomas Puusepp, President and CEO of Elekta. "This
order from University of Virginia, very shortly after receiving FDA
clearance, demonstrates the value — both to patients and financially —
that U.Va. has experienced with Gamma Knife surgery. We are looking
forward to a continued close relationship with U.Va., and we also see a
very strong interest in Leksell Gamma Knife Perfexion from other
institutions, both in the U.S. and internationally," concluded Puusepp.
When U.Va. installed its first Leksell Gamma Knife in 1989, it became
the fifth hospital in the world and the second in the USA to offer an
alternative to open brain surgery. Since then, the U.Va. Gamma Knife
Center has become a world leader in Gamma Knife surgery, now treating
more than 600 patients a year.
Drawing upon its highly qualified team of neurosurgeons and
pioneering work with Gamma Knife surgery, U.Va. offers an annual
advanced training class in the clinical practice and research of Gamma
Knife surgery for the treatment of AVMs, pituitary adenomas, acoustic
neuromas and meningiomas.
The new system provides a platform for further refinement and
expansion of radiosurgery procedures in the brain, cervical spine and
head & neck regions.
Currently installed and in clinical operation at Hospital la Timone
(University Hospital La Timone) in Marseille, France, the first patients
were successfully treated with Leksell Gamma Knife Perfexion in mid
July. In August, the U.S. Food and Drug Administration (FDA) issued a
510(k) pre-market clearance for Leksell Gamma Knife Perfexion, allowing
Elekta (STO:EKTAB) to also market the new system in the U.S. market.
See also:
First patient treated with Elekta's new non-invasive
radiotherapy system for brain tumours (July 2006) To
top
|
|